BRABOURNE

Members of the Exchange are hereby informed that the trading in equity shares of Brabourne Enterprises Limited shall be suspended w.e.f. February 03, 2010 (i.e. closing hours of trading on February 02, 2010) on account of Scheme of Arrangement between the Company, CHI Investments Limited, Octav Investments Limited and Summit Securities Limited with RPG Itochu Finance Limited.

RPG Itochu Finance Limited has informed the Exchange that February 04, 2010 has been fixed as the Record Date for implementing the Scheme of Arrangement between RPG Itochu Finance Limited and Summit Securities Limited (Summit) and Brabourne Enterprises Limited (Brabourne) and Octav Investments Limited (Octav) and CHI Investments Limited (CHI) and their respective shareholders. As per the Scheme RPG Itochu Finance Limited (RIFL) will issue equity shares to the shareholders of the erstwhile Brabourne Enterprises Limited as under, pursuant to the Scheme of Arrangement approved by the Bombay High

Brabourne Enterprises Limited had informed the Exchange that Hon'ble High Court of Judicature at Bombay has approved the Scheme of Arrangement between Summit Securities Limited and Brabourne Enterprises Limited and Octav Investments Limited and CHI Investments Limited and RPG Itochu Finance Limited and Instant Holdings Limited and KEC Holdings Limited and their Respective Shareholders on December 18, 2009.The Company has now informed the Exchange that "The certified true copy of the Order was filed with the Registrar of Companies, Maharashtra, Mumbai on December 23, 2009 and the Scheme became

Brabourne Enterprises Limited has informed the Exchange that Hon'ble High Court of Judicature at Bombay has approved the Scheme of Arrangement between Summit Securities Limited and Brabourne Enterprises Limited and Octav Investments Limited and CHI Investments Limited and RPG Itochu Finance Limited and Instant Holdings Limited and KEC Holdings Limited and their Respective Shareholders on December 18, 2009. A certified copy of the order is awaited. The Effective Date of the Scheme will be the date on which the said certified copy of the Order passed by the Hon�ble High Court is filed with the R

Brabourne Enterprises Limited has informed the Exchange that "Pursuant to the directions given by the Hon'ble High Court of Bombay under section 391 of the Companies Act, 1956, a meeting of the Equity Shareholders of the Company was held on October 23, 2009, for the purpose of considering and , if thought fit, approving with or without modifications(s), the arrangement embodied in the Scheme of Arrangement between Summit Securities Limited and Brabourne Enterprises Limited and Octav Investments Limited and CHI Investments Limited and RPG Itochu Finance Limited and Instant Holdings Limited and

Brabourne Enterprises Limited has informed the Exchange that the Company has obtained an extension of time from The Ministry of Corporate of Affairs for holding the Annual General Meeting for three months up to December 01, 2009.

Brabourne Enterprises Limited has informed the Exchange that by an Order made on September 18, 2009 in the Brabourne Enterprises Limited Company Application, the Hon'ble High Court of Judicature at Bombay has directed that a meeting of the Equity Shareholders of Brabourne Enterprises Limited, the Applicant Company, be convened and held on October 23, 2009 for the purpose of considering and, if thought fit, approving with or without modification(s), the proposed arrangement embodied in the Scheme of Arrangement between Summit Securities Limited and Brabourne Enterprises Limited and Octav Invest

Brabourne Enterprises Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on July 10, 2009 have considered and approved the proposal for amalgamation of the Company into RPG Itochu Finance Limited as per terms and conditions mentioned in the Scheme of Arrangement placed before the Board. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Brabourne_Amalg_13072009.zip target=NEW> For mo

Brabourne Enterprises Limited has informed the Exchange that the Company has chosen the option of submitting , Audited Financial Results for the entire year with three months of the end of the financial year i.e. June 30, 2009.

Brabourne Enterprises Limited has informed the Exchange that in the Board Meeting of the Company held on March 20, 2009 there was a change in the directorship of the Company as under: Directors Appointed : 1) Mr. P. A. Krishnamoorthy ; Directors Resigned : 1) Mr. Suresh Mathew ,2) Mr. J. P. Mehrotra.

Brabourne Enterprises Limited has informed the Exchange that "Ms. Archana Ramamurthy has been appointed as Company Secretary in place of Mr. Vaibhav Bakhare w.e.f. from November 7, 2008. She has also been appointed as Compliance Officer and shall carry out the duties and obligations referred in Clause 47 (a) of the Listing Agreement".

Brabourne Enterprises Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from August 25,2008 to September 2, 2008 (both days inclusive) for the purpose of Annual General Meeting.

Brabourne Enterprises Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on June 30, 2008 has adopted the accounts for the year ended on March 31, 2008.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Brabourne_Update_30062008.zip target=NEW> For more details click here.</a>

Brabourne Enterprises Limited has informed the Exchange that " With reference to voting by postal ballot conducted vide notice dated May 16, 2008, seeking assent or dissent of the members of the company on ordinary resolution in relation to appointment of Ray & Ray , Chartered Accountants, as auditors of the company. The scrutinizer has submitted his report to the chairman, and based thereon, the outcome of the above referred voting by postal ballot is as under. (1) Votes in favour: No. of votes - 6411305; % of valid votes - 99.98%. (2) Votes against: No. of votes - 1569; % of valid votes - 0

Brabourne Enterprises Limited has informed the Exchange that "Mr. H.V. Goenka, Mr. C.L. Jain, Mr. Manoj Maheshwari, Dr. Lalit S. Kanodia, Mr. P.K. Mohapatra, directors, have resigned from the board of directors of the Company".

Brabourne Enterprises Limited has informed the Exchange that:- "Mr. Dilip sen, Mr . Ajit Gulabchand, Mr. Mahesh S. Gupta, Mr. Niraj Bajaj and Mr.Arvind Vasudeva, directors have resigned from the board of directors of the company. The board of directors has appointed Mr. P. Sampath, Mr. Suresh Mathew, Mr. H.N.Singh Rajpoot, Mr. J.P.Mehrotra and Mr. T. M. Elavia as directors in casual vacancy caused by the resignation of Mr. Dilip Sen, Mr Ajit Gulabchand, Mr. Mahesh S. Gupta, Mr. Niraj Bajaj and Mr. Arvind Vasudeva respectively".

Brabourne Enterprises Limited has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, that the resolution as set out hereunder is proposed to be passed by voting by postal ballot for the purpose of appointment of auditors of the Company to hold office until conclusion of the next annual general meeting of the Company. The board of directors of the company by resolutions passed on May 16, 2008 has appointed Mr. Ashish Bhatt, proprietor of Ashish Bhatt and Associates, Company Secretaries,

Brabourne Enterprises Limited has informed the Exchange that : "The Company has decided to publish audited financial results for the financial year ended on March 31, 2008 within the time fixed under the listing agreement. Accordingly, the company shall not publish unaudited financial results for the quarter ended on March 31, 2008."

Members of the Exchange are hereby informed that the name of RPG Life Sciences Limited shall be changed to Brabourne Enterprises Limited and the trading symbol of the Company be changed from RPGLS to BRABOURNE w.e.f. March 14, 2008.

Rpg Life Sciences Limited has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2007. The details of the limited review report shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/rpg_LR_03032008.zip target=NEW> For more details click here.</a>

Rpg Life Sciences Limited has informed the Exchange that: "Mr. Vaibhav Bakhare, Company Secretary of the company, has been designated as Compliance Officer of the company".

Rpg Life Sciences Limited has informed the Exchange that: " The name of the Company has changed to 'Brabourne Enterprises Limited' from 'RPG Life Sciences Limited' consequent to Fresh Certificate of Incorporation consequent upon change of name issued by the Registrar of Companies, Maharashtra, Mumbai".

Rpg Life Sciences Limited has informed the Exchange that "Mr. Arvind Vasudeva has stepped down as Managing Director effective from February 06, 2008. This change is consequent to the sale of the pharmaceuticals business by the company to RPG Pharmaceuticals Limited (now known as RPG Life Sciences Limited) under the Scheme of Arrangement. Mr. Arvind Vasudeva has been appointed as a Managing Director of RPG Life Sciences Limited (formerly known as RPG Pharmaceuticals Limited).

Rpg Life Sciences Limited has informed the Exchange that the Scheme of Arrangement between RPG Life Sciences Limited, RPG Pharmaceuticals Limited, Instant Holdings Limited and Instant Trading and Investment Company Limited under sections 391 to 394 read with sections 100 to 103 of the Companies Act, 1956 has been sanctioned by the High Court of Judicature at Bombay and the said Scheme of Arrangement has become effective from February 05, 2008. Under the said Scheme of Arrangement, RPG Pharmaceuticals Limited will issue equity shares of face value of Rs.8/- in the ratio of 1:1 to the shareholde

Rpg Life Sciences Limited has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31,2007 (taken on record by the Board of Directors of the Company at its meeting held on January 31, 2008) that "As regards the auditors' remark on audited accounts for the previous year, 1) the loan and advances granted to the subsidiary are considered fully recoverable, 2) the company carries a provision of Rs 254 lacs against liability of Rs. 300 lacs to Hindustan Antibiotics Ltd. that may arise at the end of October 2008. The balance amount is being

Rpg Life Sciences Limited had informed the Exchange that the scheme of Arrangement between RPG Life Sciences Limited, RPG Pharmaceuticals Limited, Instant Holdings Limited and Instant Trading and Investment Company Limited under sections 391 to 394 read with sections 100 to103 of the Companies Act, 1956. The Company has now informed the Exchange that the company has received certified copy of the order from the High Court of Judicature at Bombay sanctioning the said Scheme of Arrangement. The said Scheme of Arrangement has become effective from February 05, 2008 consequent to filing of the sai

Rpg Life Sciences Limited has informed the Exchange that: "The scheme of Arrangement between RPG Life Sciences Limited, RPG Pharmaceuticals Limited, Instant Holdings Limited and Instant Trading and Investment Company Limited Under sections 391 to 394 read with sections 100 to 103 of the companies Act, 1956, has been sanctioned by the Bombay High Court. However, Copy of the order is yet to be received. We shall again intimate you on the said Scheme of Arrangement becoming effective after receipt of the copy of the order from the Bombay High Court".

Rpg Life Sciences Limited has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/RPGLifeScience_LR.zip target=NEW> For more details click here.</a>

Rpg Life Sciences Limited has informed the Exchange that "In accordance with the directions of the Hon'ble High Court of judicature at Bombay in Company Application no. 982 of 2007, meeting of equity shareholders of the company was convened and held on October 23, 2007 to consider and approve, with or without modification(s), the arrangement embodied in the Scheme. We would like to inform you that at the said meeting, the equity shareholders of the company have approved the Scheme with requisite majority".

Rpg Life Sciences Limited has informed the Exchange vide notes to Unaudited Financial Results for the quarter ended September 30, 2007 (taken on record by the Board of the directors of the Company at its Meeting held on October 23, 2007) that "As regards the auditors' remark on audited accounts for the previous year, 1) the loan and advances granted to the subsidiary are considered fully recoverable, 2) the company carries a provision of Rs 233 lacs against maximum liability of Rs. 300 lacs to Hindustan Antibiotics Ltd. that may arise at the end of October 2008. The balance amount is being pro

Rpg Life Sciences Limited has submitted to the Exchange a copy of the notice of Annual General Meeting to be held on October 23, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/RPGLife_AGM_28092007.zip target=NEW> For more details click here.</a>

Rpg Life Sciences Limited has informed the Exchange that by an Order made on the September 14, 2007 in the Company Application, the Hon'ble High Court of Judicature at Bombay has directed that a meeting of the Equity Shareholders of RPG Life Sciences Limited, the Applicant Company, be convened and held on October 23, 2007 for the purpose of considering and if thought fit to approve, with or without modification(s), the arrangement embodied in the Scheme of Arrangement ("the Scheme") between RPG Life Sciences Limited ("RPGLS") and RPG Pharmaceuticals Limited ("Operating Co") and Instant Holding

Rpg Life Sciences Limited has informed the Exchange that the Register of Members and Shares Transfer Books of the Company will remain closed from October 15, 2007 to October 23, 2007 (both days inclusive) for the purpose of Annual General Meeting and payment of Dividend, if declared.

Rpg Life Sciences Limited has informed the Exchange that : "As regards the auditor's remark on audited accounts for the previous year, (i) The loan and advances granted to the subsidiary are considered fully recoverable. (ii) The Company carries a provision of Rs 211.77 lacs against liability of Rs 300 lacs to Hindustan Antibiotics Ltd. that may arise at the end of October 2008. The balance amount is being provided @ Rs 7 lacs per month, and (iii) The Company has received approval of the central government for remuneration paid to the managing director".

Rpg Life Sciences Limited has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/RPGLife_LR_16082007.zip target=NEW> For more details click here.</a>

Rpg Life Sciences Limited has informed the Exchange that: "This has reference to issue of 19,40,000 equity shares of Rs. 10/- each for cash at a premium of Rs. 148/- per share and 6,00,000 warrants on preferential basis. These securities were allotted on March 31, 2006. This is to inform you pursuant to clause 43 of the listing agreement that as of June 2007 there has been no variation between utilization of funds for objects as stated in the explanatory statement to the notice for the general meeting convened for issue of equity shares and warrants on preferential basis, and actual utilizatio

Rpg Life Sciences Limited has informed the Exchange vide its letter dated June 12, 2007 that: "The Board of Directors of the Company at its meeting held today has considered and approved the Scheme of Arrangement between RPG Life Sciences Limited ('RPGLS' or 'the Company') and RPG Pharmaceuticals Limited ('Operating Co') and Instant Holdings Limited ('Investment Co') and Instant Trading and Investment Company Limited ('Instant')". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/

Rpg Life Sciences Limited has informed the Exchange that the Board of directors at its meeting held on June 12, 2007 has adopted the accounts for the year ended on March 31, 2007. The brief particulars of the results for the aforesaid year shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/RPGLifeSci_PR_13062007.zip target=NEW> For more details click here.</a>

Rpg Life Sciences Limited has informed the Exchange that " The auditor's remarks on accounts for the year ended on March 31, 2007 pertain to: (i) the company's investments in and loans and advances to a subsidiary, which are considered fully recoverable and a provision of Rs 5 crores made out of caution is also being carried; and (ii) the provision made by the company towards the liability that may arise only at the end of October 2008. The company during the year entered into settlement agreement with Hindustan Antibiotics Ltd. (HAL) pursuant to which the entire lease arrangement stands termi

Rpg Life Sciences Limited has informed the Exchange that the board of directors at its meeting held on June 12, 2007 has recommended a dividend of Rs.1.50/- per equity share (15%) on equity shares of face value of Rs.10/- each for the year ended on March 31, 2007.

Rpg Life Sciences Limited has informed the Exchange that "The Company has decided to publish audited financial results for the financial year ended on March 31, 2007 within the time fixed under the listing agreement. Accordingly, the company shall not publish unaudited financial results for the quarter ended on March 31, 2007."

Rpg Life Sciences Limited has informed the Exchange that "reference to voting by postal ballot conducted vide notice dated January 30, 2007, seeking assent or dissent of the members of the company on special resolution in relation to approval of appointment of and payment of remuneration to Mr. Arvind Vasudeva as managing director of the company. The scrutinizer has submitted his report to the chairman, and based thereon, the outcome of the above referred voting by postal ballot is as under. (1) Votes in favour: No. of votes - 6700015; % of valid votes - 99.90%. (2) Votes against: No. of votes

Rpg Life Sciences Limited has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2006 and found the same to be in order subject to certain observations. The auditor's observations are: (i) The auditors are unable to comment on the extent of realisability of investments made aggregating to Rs. 341,308 thousands in the shares and debentures of and loans and advances aggregating to Rs. 767,907 thousands given to 'Instant' Trading and Investment Company Limited, a wholly owned subsidiary whose net worth h

Rpg Life Sciences Limited has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, the special resolution is proposed to be passed by voting by postal ballot for the purpose of approving the appointment and payment of remuneration to Mr. Arvind Vasudeva as managing director of the company. The board of directors of the company at its meeting held on January 30, 2007 has appointed Mr. Ashish Bhatt, proprietor of Ashish Bhatt and Associates, Company Secretaries, as for conducting the posta

Rpg Life Sciences Limited has informed the Exchange that "This has reference to issue of 19,40,000 equity shares of Rs. 10/- each for cash at a premium of Rs. 148/- per share and 6,00,000 warrants on preferential basis. These securities were allotted on March 31, 2006. This is to inform you pursuant to clause 43 of the listing agreement that there has been no variation between utilization of funds for objects as stated in the explanatory statement to the notice for the general meeting convened for issue of equity shares and warrants on preferential basis, and actual utilization of funds."

Rpg Life Sciences Limited has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2006 and found the same to be in order subject to certain observations. The auditor's observations are: (i) The auditors are unable to comment on the extent of realisability of investments made aggregating to Rs. 341,308 thousands in the shares and debentures of and loans and advances aggregating to Rs. 767,907 thousands given of 'Instant' Trading and Investment Company Limited', a wholly owned subsidiary whose net worth

Members of the Exchange are hereby informed that the trading symbol of RPG Life Sciences Limited be changed from SEARLEIND to RPGLS w.e.f. December 5, 2006.

Rpg Life Sciences Limited has informed the Exchange that pursuant to the settlement agreement entered into with Hindustan Antibiotics Limited (HAL), the lease agreements with HAL and other lease related agreements stand terminated in entirely effective from February 15,2006. The aforesaid lease and other lease related agreements would have otherwise remained in force till December 2015. Consequent to earlier determination of the said agreements, the company would save about Rs. 4.80 crores per year. The board of directors at its meeting held on October 30,2006 has taken on record the terms of

Rpg Life Sciences Limited has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2006 and found the same to be in order subject to certain observations. The auditor's observations are: The auditors are unable to comment on the extent of realisability of investments made aggregating to Rs. 341,308 thousands in the shares and debentures of and loans and advances aggregating to Rs. 767,905 thousands given of 'Instant' Trading and Investment Company Limited, a wholly owned subsidiary whose net worth has been

Rpg Life Sciences Limited has informed the Exchange that Remuneration/Compensation committee at meeting held on August 25,2006 has granted option for 40,000 equity shares to managing director of the company, with exercise price fixed at Rs 119 per equity share (being price higher than the closing price on NSE on day prior to the date of the meeting). This option shall vest one fifth on linier scale, based on performance every year, after one year from the date of grant. As per rules of 2005 ESOP, option can be exercised any time within ten years from the respective date of vesting subject to o